AMCR vs PAHC · P/E 18, rev $23.51B vs P/E 13, rev $1.52B
Amcor PLC (AMCR) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the AMCR and PAHC stock pages for the full models.
Not investment advice.